04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
In this episode of the FCPA Compliance Report, I visit Justin Muscolino, Head of North American Comp...
Read More >
Whether California’s recently adopted “ABC” test, used in the employee-versus-independent contrac...
Read More >
Dear Legal Mailbag: It is that time again. My superintendent sent out the annual memorandum last we...
Read More >
On October 13, 2019, California Governor Gavin Newsom signed Assembly Bill (AB) 51 into law, banning...
Read More >
On August 12, Governor Cuomo signed sweeping new legislation toughening and substantially broadening...
Read More >
Valentine’s Day is fast approaching, which means love in the air – and employers should beware. St...
Read More >